• Home
  • About Us
    • About EFG
    • Our Mission
    • Careers
  • Specialized Services
    • Business Owners
    • Federal Employees
    • Individuals and Families
  • News
  • Resources
    • Workshop / Webinar Topics
  • Contact Us
Elite Financial Group

Stock futures rise slightly ahead of Powell’s Jackson Hole speech: Live updates

by Elite Financial Group | Aug 22, 2025 | Breaking News

Investors will parse through the Fed chief’s speech for clues into future monetary policy.Read More…

John Deere faces a crossroads amid decreasing demand, increasing investments

by Elite Financial Group | Aug 22, 2025 | Breaking News

John Deere has reported significant hits from weaker agricultural demand, but Wall Street still sees optimism for the company’s road ahead.Read More…

Are you smart enough to invest in private assets? Designing an investor test is tricky, experts say

by Elite Financial Group | Aug 22, 2025 | Personal Finance

Some lawmakers want a knowledge test to be able to invest in private assets — which are less regulated and riskier than public ones.Read More…

Nvidia in talks with U.S. to sell a more advanced chip to China, Jensen Huang says

by Elite Financial Group | Aug 22, 2025 | Breaking News

Nvidia’s issues in China are mounting, even after the U.S. government approved the H20 for export to the Asian country.Read More…

Google scores six-year Meta cloud deal worth over $10 billion

by Elite Financial Group | Aug 22, 2025 | Breaking News

Alphabet and Meta compete in online advertising, but Meta needs more data center infrastructure as it pursues artificial intelligence growth.Read More…
« Older Entries
Next Entries »

Recent Posts

  • Stock futures are little changed after Dow’s record close, as traders await Nvidia earnings: Live updates
  • Global week ahead: Trump’s Nobel dreams meet economic reality
  • How the U.S. space industry became dependent on SpaceX
  • Solar executives warn that Trump attack on renewables will lead to power crunch that spikes electricity prices
  • Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

Categories

  • Breaking News
  • Financial Services
  • Personal Finance

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Designed & Powered by BEZA.NET